SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-14-000878
Filing Date
2014-03-28
Accepted
2014-03-28 16:31:30
Documents
16
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10k.htm 10-K 1137195
2 GRAPHIC img.jpg GRAPHIC 7516
3 EXHIBIT 3.2 ex3-2.htm EX-3.2 273357
4 EXHIBIT 10.27 ex10-27.htm EX-10.27 159099
5 EXHIBIT 10.28 ex10-28.htm EX-10.28 18123
6 EXHIBIT 10.29 ex10-29.htm EX-10.29 31658
7 EXHIBIT 23.1 ex23-1.htm EX-23.1 3435
8 EXHIBIT 31.1 ex31-1.htm EX-31.1 14352
9 EXHIBIT 31.2 ex31-2.htm EX-31.2 21733
10 EXHIBIT 32.1 ex32-1.htm EX-32.1 6261
  Complete submission text file 0001493152-14-000878.txt   8512699

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE immy-20131231.xml EX-101.INS 943868
12 XBRL SCHEMA FILE immy-20131231.xsd EX-101.SCH 73403
13 XBRL CALCULATION FILE immy-20131231_cal.xml EX-101.CAL 57703
14 XBRL DEFINITION FILE immy-20131231_def.xml EX-101.DEF 234757
15 XBRL LABEL FILE immy-20131231_lab.xml EX-101.LAB 526710
16 XBRL PRESENTATION FILE immy-20131231_pre.xml EX-101.PRE 342823
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 14726173
SIC: 2834 Pharmaceutical Preparations